Pete Lollar

6.5k total citations
138 papers, 5.4k citations indexed

About

Pete Lollar is a scholar working on Hematology, Genetics and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Pete Lollar has authored 138 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 117 papers in Hematology, 40 papers in Genetics and 26 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Pete Lollar's work include Hemophilia Treatment and Research (102 papers), Blood Coagulation and Thrombosis Mechanisms (70 papers) and Platelet Disorders and Treatments (58 papers). Pete Lollar is often cited by papers focused on Hemophilia Treatment and Research (102 papers), Blood Coagulation and Thrombosis Mechanisms (70 papers) and Platelet Disorders and Treatments (58 papers). Pete Lollar collaborates with scholars based in United States, Germany and United Kingdom. Pete Lollar's co-authors include Ernest T. Parker, John F. Healey, Carlo Parker, Rachel T. Barrow, Whyte G. Owen, David N. Fass, David C. Hill‐Eubanks, Christopher B. Doering, Dorothea Scandella and Shannon L. Meeks and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Pete Lollar

136 papers receiving 5.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Pete Lollar 4.2k 1.5k 1.1k 634 566 138 5.4k
J Guichard 2.5k 0.6× 975 0.6× 916 0.8× 324 0.5× 134 0.2× 77 4.0k
Luc Douay 1.9k 0.5× 1.1k 0.7× 1.4k 1.2× 289 0.5× 130 0.2× 143 4.4k
Nydia G. Testa 1.4k 0.3× 681 0.5× 830 0.7× 255 0.4× 263 0.5× 105 3.0k
AC Eaves 4.2k 1.0× 2.1k 1.4× 1.6k 1.4× 612 1.0× 107 0.2× 83 6.0k
Katharina S. Götze 2.7k 0.7× 1.3k 0.8× 1.7k 1.6× 152 0.2× 120 0.2× 130 3.9k
Martin Wermke 2.2k 0.5× 885 0.6× 1.2k 1.1× 213 0.3× 110 0.2× 152 3.7k
Gerald M. Segal 2.5k 0.6× 1.4k 0.9× 953 0.8× 137 0.2× 103 0.2× 20 3.9k
Torben Plesner 3.2k 0.8× 905 0.6× 2.2k 1.9× 277 0.4× 670 1.2× 169 5.6k
P Mannoni 1.5k 0.3× 447 0.3× 1.2k 1.1× 479 0.8× 280 0.5× 128 3.5k
Mark Kirschbaum 3.2k 0.8× 887 0.6× 1.9k 1.7× 205 0.3× 249 0.4× 66 6.2k

Countries citing papers authored by Pete Lollar

Since Specialization
Citations

This map shows the geographic impact of Pete Lollar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pete Lollar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pete Lollar more than expected).

Fields of papers citing papers by Pete Lollar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pete Lollar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pete Lollar. The network helps show where Pete Lollar may publish in the future.

Co-authorship network of co-authors of Pete Lollar

This figure shows the co-authorship network connecting the top 25 collaborators of Pete Lollar. A scholar is included among the top collaborators of Pete Lollar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pete Lollar. Pete Lollar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sastre, Diego E., Nazneen Sultana, M.V.A.S. Navarro, et al.. (2024). Human gut microbes express functionally distinct endoglycosidases to metabolize the same N-glycan substrate. Nature Communications. 15(1). 7 indexed citations
2.
Davulcu, Omar, et al.. (2024). Cryoem Structures and Conformational Landscapes of Activated Blood Coagulation Factor VIII and the Intrinsic Tenase Complex. Blood. 144(Supplement 1). 428–428. 1 indexed citations
3.
Davulcu, Omar, et al.. (2023). Structure of coagulation factor VIII bound to a patient-derived anti-C1 domain antibody inhibitor. Blood. 142(2). 197–201. 3 indexed citations
4.
Lollar, Pete, et al.. (2022). SAXS analysis of the intrinsic tenase complex bound to a lipid nanodisc highlights intermolecular contacts between factors VIIIa/IXa. Blood Advances. 6(11). 3240–3254. 5 indexed citations
5.
Parker, Ernest T., et al.. (2022). Type 2B von Willebrand disease mutations differentially perturb autoinhibition of the A1 domain. Blood. 141(10). 1221–1232. 4 indexed citations
6.
Cao, Wenpeng, Yingchun Wang, Asif Shajahan, et al.. (2021). Desialylation of O‐glycans activates von Willebrand factor by destabilizing its autoinhibitory module. Journal of Thrombosis and Haemostasis. 20(1). 196–207. 7 indexed citations
7.
Parker, Ernest T. & Pete Lollar. (2021). Conformation of the von Willebrand factor/factor VIII complex in quasi-static flow. Journal of Biological Chemistry. 296. 100420–100420. 12 indexed citations
8.
Smith, Ian W. M., Anne E. d’Aquino, Andrew Fedanov, et al.. (2019). The 3.2 Å structure of a bioengineered variant of blood coagulation factor VIII indicates two conformations of the C2 domain. Journal of Thrombosis and Haemostasis. 18(1). 57–69. 17 indexed citations
9.
Doering, Christopher B., Gabriela Denning, Eli J. Fine, et al.. (2018). Preclinical Development of a Hematopoietic Stem and Progenitor Cell Bioengineered Factor VIII Lentiviral Vector Gene Therapy for Hemophilia A. Human Gene Therapy. 29(10). 1183–1201. 45 indexed citations
10.
Deng, Wei, et al.. (2018). Delimiting the autoinhibitory module of von Willebrand factor. Journal of Thrombosis and Haemostasis. 16(10). 2097–2105. 18 indexed citations
11.
Batsuli, Glaivy, W. Hunter Baldwin, Courtney Cox, et al.. (2018). Anti‐C1 domain antibodies that accelerate factor VIII clearance contribute to antibody pathogenicity in a murine hemophilia A model. Journal of Thrombosis and Haemostasis. 16(9). 1779–1788. 10 indexed citations
12.
Deng, Wei, Yanming Wang, John F. Healey, et al.. (2017). A discontinuous autoinhibitory module masks the A1 domain of von Willebrand factor. Journal of Thrombosis and Haemostasis. 15(9). 1867–1877. 36 indexed citations
13.
Healey, John F., Ernest T. Parker, & Pete Lollar. (2017). Identification of aggregates in therapeutic formulations of recombinant full‐length factor VIII products by sedimentation velocity analytical ultracentrifugation. Journal of Thrombosis and Haemostasis. 16(2). 303–315. 13 indexed citations
14.
Batsuli, Glaivy, Wei Deng, John F. Healey, et al.. (2016). High-affinity, noninhibitory pathogenic C1 domain antibodies are present in patients with hemophilia A and inhibitors. Blood. 128(16). 2055–2067. 31 indexed citations
15.
Lewis, Kenneth B., Ruth A. Ettinger, Jason T. Schuman, et al.. (2014). High-resolution mapping of epitopes on the C2 domain of factor VIII by analysis of point mutants using surface plasmon resonance. Blood. 123(17). 2732–2739. 24 indexed citations
16.
Walter, Justin D., et al.. (2013). Characterization and Solution Structure of the Factor VIII C2 Domain in a Ternary Complex with Classical and Non-classical Inhibitor Antibodies. Journal of Biological Chemistry. 288(14). 9905–9914. 14 indexed citations
17.
Parker, Ernest T., et al.. (2004). Comparative immunogenicity of recombinant B domain-deleted porcine factor VIII and Hyate:C in hemophilia A mice presensitized to human factor VIII. Journal of Thrombosis and Haemostasis. 2(4). 605–611. 26 indexed citations
18.
Doering, Christopher B., John F. Healey, Ernest T. Parker, Rachel T. Barrow, & Pete Lollar. (2002). High Level Expression of Recombinant Porcine Coagulation Factor VIII. Journal of Biological Chemistry. 277(41). 38345–38349. 87 indexed citations
19.
Chang, Jinli, Jianping Jin, Pete Lollar, et al.. (1998). Changing Residue 338 in Human Factor IX from Arginine to Alanine Causes an Increase in Catalytic Activity. Journal of Biological Chemistry. 273(20). 12089–12094. 78 indexed citations
20.
Bode, Wolfram, Pete Lollar, Margit Bauer, Robert Huber, & Hans Brandstetter. (1996). Crystal Structure of the Antihaemophilic Clotting Factor IXa:Explanation for Its Activity Enhancement towards Factor X upon Complex Formation with Factor VIIIa. 7(3). 165–175.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Guichard Breakdown of academic impact, for papers by Luc Douay Breakdown of academic impact, for papers by Nydia G. Testa Breakdown of academic impact, for papers by AC Eaves Breakdown of academic impact, for papers by Katharina S. Götze Breakdown of academic impact, for papers by Martin Wermke Breakdown of academic impact, for papers by Gerald M. Segal Breakdown of academic impact, for papers by Torben Plesner Breakdown of academic impact, for papers by P Mannoni Breakdown of academic impact, for papers by Mark Kirschbaum
Rankless by CCL
2026